High-affinity renal lead-binding proteins in environmentally-exposed humans

Chemico-Biological Interactions

Volumn 115, Issue 1, 1998, Pages 39-52

  Smith, D R ^a   Kahng, M W ^b   Quintanilla Vega, B ^c   Fowler, B A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

ACBP (DBI); Kidney; Lead; Metals; Proteins; Thymosin 4; Toxicity

Indexed keywords

BINDING PROTEIN; DIAZEPAM BINDING INHIBITOR; THYMOSIN BETA4;

ADULT; ARTICLE; BINDING AFFINITY; CASE REPORT; ENVIRONMENTAL EXPOSURE; HUMAN; HUMAN TISSUE; KIDNEY PARENCHYMA; LEAD POISONING; MALE; PROTEIN ANALYSIS; PROTEIN BINDING;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIAZEPAM BINDING INHIBITOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENVIRONMENTAL EXPOSURE; HUMANS; KIDNEY CORTEX; LEAD; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; THYMOSIN;

ANIMALIA; INVERTEBRATA; MAMMALIA;

EID: 0031928694     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00060-X     Document Type: Article

References (40)

1. M. Payton, H. Hu, D. Sparrow, S.T. Weiss, Low-level lead exposure and renal function in the Normative Aging Study, Am. J. Epidemiol. 140 (1994) 821-829.
2. J.A. Staessen, R.R. Lauwerys, J.P. Buchet, C.J. Bulpitt, D. Rondia, Y. Vanrenterghem, A. Amery, Impairment of renal function with increasing blood lead concentrations in the general population. The cadmibel study group, New Engl. J. Med. 327 (1992) 151-156.
3. A.M Bernard, A. Vyskocil, H. Roels, J. Kriz, M. Kodl, R. Lauwerys, Renal effects in children living in the vicinity of a lead smelter, Environ. Res. 68 (1995) 91-95.
4. H.L. Needleman, J.A. Riess, M.J. Tobin, G.E. Biesecker, J.B. Greenhouse, Bone lead levels and delinquent behavior, J. Am. Med. Assoc. 275 (1996) 363-369.
5. D.C. Bellinger, K.M. Stiles, H.L. Needleman, Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study, Pediatrics 90 (1992) 855-861.
6. A.C. dos Santos, S. Colacciopo, C.M. Dal Bo, N.A. dos Santos, Occupational exposure to lead, kidney function tests, and blood pressure, Am. J. Ind. Med. 26 (1994) 635-643.
7. A.I. Sanchez-Fructuoso, A. Torralbo, M. Arroyo, et al., Occult lead intoxication as a cause of hypertension and renal failure, Nephrol. Dial. Transplant 11 (1996) 1775-1780.
8. G.F. Nordberg, Modulation of metal toxicity by metallothionein, Biol. Trace Elem. Res. 21 (1989) 131-135.
9. K.S. Squibb, B.A. Fowler, Intracellular metabolism and effects of circulating cadmium-metalloth-ionein in the kidney, Environ. Health Persp. 54 (1984) 31-35.
10. B.A. Fowler, Intracellular metabolism and effects of circulating cadmium-metallothionein in the kidney, Environ. Health Persp. 100 (1992) 57-63.
11. P.L. Goering, B.A. Fowler, Regulation of lead inhibition of delta-aminolevulinic acid dehydratase by a low molecular weight, high affinity renal lead-binding protein, J. Pharmacol. Exp. Ther. 231 (1984) 66-71.
12. P.L. Goering, B.A. Fowler, Mechanism of renal lead-binding protein reversal of delta-aminolevulinic acid dehydratase inhibition by lead, J. Pharmacol. Exp. Ther. 234 (1985) 365-371.
13. B. Quintanilla-Vega, D.R. Smith, M.W. Kahng, J.M. Hernandez, A. Albores, B. Fowler, Lead-binding proteins in brain tissue of environmentally-lead exposed humans, Chem. Biol. Interac. 98 (1995) 193-209.
14. D.R. Smith, F. McNeill, In vivo measurement and speciation of nephrotoxic metals., Target Organ Toxicology: Renal Toxicology of Metals, vol. II, CRC Press, Boca Raton, FL, 1996, pp. 737-750.
15. D.R. Smith, J. Osterloh, S. Niemeyer, A.R. Flegal, Stable isotope labeling of lead compartments in rats with ultra-low lead concentrations, Environ. Res. 57 (1992) 190-207.
16. D.R. Smith, M.W. Kahng, E.A. Conner, B.A. Fowler, Isolation and purification of cytosolic lead-binding polypeptides in human kidney, Toxicologist 13 (1993) 443.
17. G. DuVal, B.A. Fowler, Preliminary purification and characterization studies of a low molecular weight, high affinity cytosolic lead-binding protein in rat brain, Biochem. Biophys. Res. Commun. 159 (1989) 177-1845.
18. P.L. Goering, P. Mistry, B.A. Fowler, A low molecular weight lead-binding protein in brain attenuates lead inhibition of delta-aminolevulinic acid dehydratase: comparison with a renal lead-binding protein, J. Pharmacol. Exp. Ther. 237 (1986) 220-225.
19. B.A. Fowler, M.W. Kahng, D.R. Smith, E.A. Conner, N.K. Laughlin, Implications of lead-binding proteins for risk assessment of lead exposure, J. Exp. Anal. Environ. Epidemiol. 3 (1993) 441-448.
20. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature (London) 227 (1970) 680-685.
21. E.A. Conner, B.A. Fowler, Preliminary purification and partial characterization studies of a low-molecular weight cytosolic lead-binding protein in liver of the channel catfish (Ictalurus punctatus), Aquat. Toxicol. 28 (1994) 29-36.
22. P.M. Eagle, K.R. Shelton, Chronic lead intoxication causes a brain-specific nuclear protein to accumulate in the nuclei of cells lining kidney tubules, J. Biol. Chem. 261 (1986) 2294-2298.
23. P. Guarneri, A. Berkovich, A. Guidotti, E. Costa, A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brain, Neuropharmacol. 29 (1990) 419-428.
24. C.M. Smith, X. Wang, H. Hu, K.T. Kelsey, A polymorphism in the delta-aminolevulinic acid dehydratase gene may modify the pharmacokinetics and toxicity of lead, Environ. Health Perspect. 103 (1995) 248-253.
25. M.C. Sanders, A.L. Goldstein, X.L. Wang, Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells, Proc. Natl. Acad. Sci. 89 (1992) 4678.
26. M. Kolmer, H. Alho, E. Costa, L. Pani, Cloning and tissue-specific functional characterization of the promoter of the rat diazepam binding inhibitor, a peptide with multiple biological actions, Proc. Natl. Acad. Sci. 90 (1993) 8439-8443.
27. R.E. Gossett, A.A. Frolov, J.B. Roths, W.D. Behnke, A.B. Kier, F. Schroeder, Acyl-CoA binding proteins: multiplicity and function, Lipids 9 (1996) 895-919.
28. M.F. Carlier, D. Didry, I. Erk, J. Lepault, M.L. Van Troys, J. Vandekerckhove, I. Perelroizen, H. Yin, Y. Doi, D. Pantaloni, Tbeta 4 is not a simple G-actin sequestering protein and interacts with F-actin at high concentration, J. Biol. Chem. 271 (1996) 9231-9239.
29. W. Voelter, A. Kapuzniotu, M. Mihelic, B. Gurvits, G. Abrahamian, A. Galoyan, The interaction of (1-4)-fragment of thymosin beta 4 with calmodulin-sensitive cAMP phosphodiesterase from hypothalamus, Neurochem. Res. 20 (1995) 55-59.
30. N.R. Hall, J.P. McGillis, B.L. Spangelo, A.L. Goldstein, Evidence that thymosins and other biologic response modifiers can function as neuroactive immunotransmitters, J. Immunol. 135 (1985) 806.
31. E. Costa, A. Guidotti, Diazepam binding inhibitor (DBI): a peptide with multiple biological actions, Life Sci. 49 (1991) 325-344.
32. V. Papadopoulos, A.S. Brown, Role of the peripheral-type benzodiazepine receptor and the polypeptide diazepam binding inhibitor in steroidogenesis, J. Steroid Biochem. Mol. Biol. 53 (1995) 103-110.
33. K.-H. Herzig, I. Schon, K. Tatemoto, Y. Ohe, Y. Li, U.R. Folschm, C. Owyang, Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine, Proc. Natl. Acad. Sci. 93 (1996) 7927-7932.
34. J.A. Ball, M.A. Ghatei, K. Sekiya, T. Krausz, S.R. Bloom, Diazepam binding inhibitor-like immunoreactivity(51-70): distribution in human brain, spinal cord and peripheral tissues, Brain Res. 479 (1989) 300-305.
35. H. Fyrst, J. Knudsen, M.A. Schott, B.H. Lubin, R.A. Kuypers, Detection of acyl-CoA-binding protein in human red blood cells and investigation of its role in membrane phospholipid renewal, Biochem. J. 306 (1995) 793-799.
36. A. Oskarsson, B.A. Fowler, Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function, Exper. Molec. Pathol. 43 (1985) 397-408.
37. M. Lamacz, M.C. Tonon, F. Smih-Rouet, C. Patte, P. Gasque, M. Fontaine, H. Vaudry, The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes, Molec. Brain Res. 37 (1996) 290-296.
38. S. Mandrup, R. Hummel, S. Ravn, G. Jensen, P.H. Andreasen, N. Gregersen, J. Knudsen, K. Kristiansen, Acyl-CoA-binding protein/diazepam-binding inhibitor gene and pseudogenes. A typical housekeeping gene family, J. Molec. Biol. 228 (1992) 1011-1022.
39. P. Carpinterio, R. Anadon, F.F. del Amo, J. Gomez-Marquez, The thymosin beta 4 gene is strongly activated in neural tissues during early postimplantation mouse development, Neurosci. Lett. 184 (1995) 63-66.
40. M. Malagon, H. Vaudry, F. Van Strien, G. Pelletier, F. Garcia-Navarro, M.C. Tonon, Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain, Neuroscience 57 (1993) 777-786.